SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15220256
Source:
http://linkedlifedata.com/resource/pubmed/id/15220256
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0025598
,
umls-concept:C0026192
,
umls-concept:C0032659
,
umls-concept:C0038766
,
umls-concept:C0087111
,
umls-concept:C0178602
,
umls-concept:C0205174
,
umls-concept:C0205289
,
umls-concept:C0220825
,
umls-concept:C0220922
,
umls-concept:C0289313
,
umls-concept:C0442027
,
umls-concept:C0450442
,
umls-concept:C1280519
,
umls-concept:C1524062
,
umls-concept:C2700280
pubmed:issue
7
pubmed:dateCreated
2004-6-28
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15220256-15562243
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7805975
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Metformin
,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones
,
http://linkedlifedata.com/resource/pubmed/chemical/rosiglitazone
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0149-5992
pubmed:author
pubmed-author:DavidsonMayer BMB
,
pubmed-author:NavarMariaM
,
pubmed-author:PalomenoGladysG
,
pubmed-author:RamanT KTK
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1741-2
pubmed:meshHeading
pubmed-meshheading:15220256-Algorithms
,
pubmed-meshheading:15220256-Diabetes Mellitus, Type 2
,
pubmed-meshheading:15220256-Dose-Response Relationship, Drug
,
pubmed-meshheading:15220256-Drug Therapy, Combination
,
pubmed-meshheading:15220256-Female
,
pubmed-meshheading:15220256-Humans
,
pubmed-meshheading:15220256-Hypoglycemic Agents
,
pubmed-meshheading:15220256-Los Angeles
,
pubmed-meshheading:15220256-Male
,
pubmed-meshheading:15220256-Metformin
,
pubmed-meshheading:15220256-Middle Aged
,
pubmed-meshheading:15220256-Minority Groups
,
pubmed-meshheading:15220256-Reproducibility of Results
,
pubmed-meshheading:15220256-Thiazolidinediones
pubmed:year
2004
pubmed:articleTitle
Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population.
pubmed:affiliation
Clinical Trials Unit, Charles R Drew University, Los Angeles, CA 90059, USA.
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Controlled Clinical Trial